KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Amortizatization of Intangibles (2016 - 2025)

Globus Medical (GMED) has disclosed Amortizatization of Intangibles for 13 consecutive years, with $53000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles rose 100.05% year-over-year to $53000.0, compared with a TTM value of $215.8 million through Sep 2025, up 309.36%, and an annual FY2024 reading of $215.4 million, up 200.63% over the prior year.
  • Amortizatization of Intangibles was $53000.0 for Q3 2025 at Globus Medical, down from $421000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $215.3 million in Q4 2024 and bottomed at -$107.2 million in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $15.5 million, with a median of -$501000.0 recorded in 2021.
  • The sharpest move saw Amortizatization of Intangibles crashed 2500.0% in 2021, then surged 35417.43% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$1.0 million in 2021, then grew by 7.37% to -$943000.0 in 2022, then soared by 5676.99% to $52.6 million in 2023, then soared by 309.39% to $215.3 million in 2024, then tumbled by 99.98% to $53000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for GMED at $53000.0 in Q3 2025, $421000.0 in Q1 2025, and $215.3 million in Q4 2024.